IL2 and systemic lupus erythematosus: Although the pathophysiological relevance of this finding was unclear at this time, following studies demonstrated a recovery from autoimmunity in the MRL/lpr lupus mouse model after vaccination with an IL-2 expressing recombinant vaccinia virus, providing the first evidence that IL-2 therapy could be an effective treatment for SLE (42).